The global Skin Tears Treatment Market was valued at US$ 433.5 Million in 2021 and is expected to reach US$ 569.4 Million by 2029, finds Future Market Insights (FMI) in a recent market survey.
| Data Points | Market Insights |
|---|---|
| Market Value 2021 | USD 433.5 Million |
| Market Value 2022 | USD 446.2 Million |
| Market Value 2029 | USD 569.4 Million |
| CAGR 2022 to 2029 | 3.5% |
| Key Players | The key players are 3M Health Care; ACell, Inc.; BSN Medical GmbH (Essity AB); Cardinal Health, Inc.; Coloplast A/S; ConvaTec Group Plc; Covalon Technologies Ltd.; Medline Industries, Inc.; Mölnlycke Health Care AB; Smith and Nephew Plc; Hollister Inc.; Avery Dennison Corporation; Geistlich Pharma AG; Richardson Healthcare Ltd; Stedical Scientific; and Anika Therapeutics, Inc. |
| Share of Top 5 Countries | 50.7% |
The growing prevalence of chronic injuries, rising geriatric population, growing inclination towards novel skin tear practices, and increase in the number of steps taken by the government to raise awareness regarding wound care and management are primary factors boosting the growth of the skin tears treatment market. Moreover, the growing number of patients detected with lifestyle-associated disorders leading to chronic wounds like diabetic foot ulcers, venous leg ulcers, and pressure ulcers is expected to drive the market growth further.
Skin Tears Treatment market holds nearly 1.9 % market value share of the US$ 23 Billion wound care market in 2021. In addition, increasing awareness among patients and physicians about the benefits related to the adoption of advanced wound care over the current conventional method of handling skin injuries is leading to the growth of the skin tears treatment market.
Since one of the main concerns of the skin tears treatment market is the lack of knowledge about skin tears and their treatment. Many companies offer free online programs that are open to both healthcare professionals and the general public. Thus, the development of educational programs by companies not only increases the awareness of skin tears but also can be used as a tool for marketing their products.
Driven by this, sales of skin tears treatment are expected to rise at a 3.5% CAGR through 2029.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 3.29% |
| H1, 2022 Projected | 3.54% |
| H1, 2022 Outlook | 3.44% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (+) 15 ↑ |
According to Future Market Insights Analysis, the global skin tears treatment market is expected to observe a surge in the Basis Point Share (BPS) value by nearly 15 units in H1- 2022 (O) as compared to H1-2021. However, when comparing the growth rate for the H1-2022 projected period and the H1-2022 outlook period, a decline in the growth rate by 10 BPS has been observed.
This is majorly due to the greater prevalence of chronic wounds, pressure ulcers, obesity, foot ulcers, and venous ulcers. The rising burden of wound incidence owed to these factors contributes majorly to this increase in the BPS value.
The dearth of investigations into the risk factors which lead to skin tears, which represent a common condition of traumatic wounds, is associated with a restrictive outlook in terms of its impact on the overall skin tears treatment market. The market growth is subject to changes associated with industry dynamics, and influential factors such as the volume of disease burden, globally.
The introduction of advanced hydrogels as dressings for wound care, utilization of natural sources for hydrogel production, reinforcement of hydrogels with the incorporation of nanoparticles, and deployment of smart hydrogels are some advancements in the skin tears treatment market and are marked as recent key developmental factors for the industry
Sales of skin tears treatment grew at a CAGR of 2.3% between 2014 and 2021.
The primary factors boosting the skin tears treatment market growth are the growing incidence of acute injuries and wounds, and the inclination towards advanced skin tears therapy.
Efforts to reduce the period of hospital stay so as to decrease surgical healthcare costs and the increasing inclination toward products that improve therapeutic results are other factors adding to the growth of the skin tears treatment market.
In addition, healthcare facilities are concentrating on conducting various educational programs to increase awareness amongst healthcare professionals regarding skin tear management. Moreover, government initiatives, a growing aging population, technological advancements, and a pressing demand for safer and rapid treatment of chronic and acute wounds are fueling the skin tears therapy market. Also, the capability of these dressings to be utilized as primary or secondary dressings for accidents or other serious incidences is anticipated to support their adoption.
Considering this, FMI expects the global skin tears treatment market to grow at a CAGR of 3.5% through 2029.
Principal Consultant
The high cost of skin tear dressing and the dearth of skilled professionals are the major factors hampering the growth of the market. Traditional wound care dressings are economical in comparison. But, these products have lower therapeutic efficacy when compared with advanced wound care dressings used for skin tears treatment.
This is particularly true for emerging nations where expenditure for wound care is low, and awareness regarding skin tears is also low. The preference for traditional wound care products over skin tears treatment products still continues to grow in these regions which might hamper the market growth in the future.
Low awareness about the available treatment preferences for skin tear and the different modalities of treatment available in the market are factors likely to reduce the demand for these products. Another important factor restraining the skin tears treatment market includes the associated slow penetration rate due to the lack of availability of favorable reimbursement policies for skin tear treatment.
In various countries, skin tears are still identified and termed as skin lacerations and accordingly the treatment is provided. The lack of clarity has an effect on the reimbursement of the products since they are not classified under a separate category in many countries including India, China, and similar developing countries.
All these factors are bound to hamper the market growth during the forecast period if not addressed properly and very soon.
The USA is estimated to account for around 91.0% of the North American skin tears treatment market in 2022.
USA dominates the skin tears treatment market owing to the growing incidence of chronic as well as acute wounds, the increase in the aging population, and favorable reimbursement policies. The healthcare business in the USA is one of the most mature and flourished markets, in terms of product availability and innovations.
Obesity, diabetes, and other chronic diseases are a few factors adding to the increasing incidence of chronic wounds. A study carried out by the WHS (Wound Healing Society), in the United States of America, showed that around 8.2 million patients had wounds with or without infection in the United States during 2018.
Germany is estimated to account for 20.9% of the Europe skin tears treatment market in 2022.
The development of the market in Germany is owing to increasing cases of diabetic foot ulcers, rising government initiatives to increase awareness regarding available treatment options, and growing healthcare spending in the country. Germany is expected to show significant growth in the skin tears treatment market owing to growing awareness among people regarding skin tears. For instance, the European Wound Management Association has lately published a short-course program on skin diseases teaching people via several campaigns, which is boosting the market in Germany.
The skin tears treatment market in China is estimated to be worth US$ 34.5 Million in 2022 in the global market.
In China, the skin tears treatment market is mainly driven by the growing geriatric population, the increasing number of local players, and growing technological advancements.
According to the latest report on the geriatric population, in 2020, around 264 million people are over 60 years of age and around 191 million people are over 65 years of age. The old age population is more susceptible to chronic wounds and serious injuries which are leading to the growth of the market in China. Also, the wound healing process in elderly people is slower than in other age groups, which increases the demand for rapid wound care thus leading to the growth of the market.
Demand for skin tears treatment in India is expected to rise at around 4.8% CAGR over the forecast period.
India is anticipated to grow at an impressive rate due to the surging number of road accident injuries, improving healthcare infrastructure, and growing new product launches. Road accidents lead to acute to severe wounds which require immediate care that are expected to add to the market growth in India.
For instance, as per the NCRB (National Crime Records Bureau) data, road mishaps in India left around 442,996 people injured and about 181,113 people dead in 2019. Therefore, the skin tears treatment market is in high demand in India.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By Product, moisture-retentive dressing is anticipated to hold the maximum share of 53.8% in 2022, expanding at a rate of nearly 2.6% during the forecast period.
Skin tears treatment grounded on moisture-retentive advance wound dressing, particularly foam dressing, observes higher demand in comparison to other dressing counterparts. It allows fast epithelialization, reduces infection, fibrosis, and, pain, and yields improved results. Hydrogel dressings are the most broadly adopted methods of wound dressing.
Made of approximately 90% water, hydrogels offer sufficient moisture that can boost healing time Furthermore, the capacity of these dressings to be utilized as primary or secondary for accidents or other serious injuries is anticipated to surge their adoption.
By type of skin tear, type 1 skin tear will lead the market and is projected to account for 38.0% of the total market revenue share in 2022.
Type 1 Skin Tear is a type of wound where there is no permanent loss of skin. In most cases, the wounds due to chronic diseases or road accident injuries are not permanent and do not lead to severe injuries and no skin loss. These can be easily treated by wound dressings and hence lead to an increase in demand for the skin tears treatment market.
By distribution channel, the retail pharmacies segment is anticipated to hold the maximum share of 34.8% in 2022, expanding at a rapid rate of 4.1% CAGR during the forecast period.
The growing demand for faster treatment and ease of accessibility to advanced products is leading to the growing market share of retail pharmacies. Factors such as passing advantages to patients and consumers, technology-driven pharmacies, increase in market profits and share and economies of scale increase the patient preference towards retail pharmacies. Moreover, to prevent surgeries, patients move towards medical treatment which increases opportunities for the market.
Companies operating in the skin tears treatment market are competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances. The product launch and acquisition accelerate the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market. Some of the recent instances include:
| Attribute | Details |
|---|---|
| Forecast Period | 2014 to 2021 |
| Historical Data Available for | 2022 to 2029 |
| Market Analysis | USD Million for Value |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa, Northern Africa |
| Key Segments Covered | Product, Type of Skin Tear, Distribution Channel, and Region |
| Key Companies Profiled | 3M Health Care; ACell, Inc.; BSN Medical GmbH (Essity AB); Cardinal Health, Inc.; Coloplast A/S; ConvaTec Group Plc; Covalon Technologies Ltd.; Medline Industries, Inc.; Mölnlycke Health Care AB; Smith and Nephew Plc; Hollister Inc; Avery Dennison Corporation; Geistlich Pharma AG; Richardson Healthcare Ltd; Stedical Scientific; Anika Therapeutics, Inc. |
| Report Coverage | Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities and Threat Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global skin tears treatment market is worth US$ 433.5 Million in 2021 and is set to expand 1.3X over the forecasted years owing to the rising number of chronic wounds and rising awareness regarding available treatment options.
The sales of skin tears treatment in the market have grown at a CAGR of nearly 2.3% between 2014 and 2021. The need for skin tears treatment is growing because of increasing awareness among patients and physicians about the benefits related to the adoption of advanced wound care over the current conventional method of handling skin injuries.
The skin tears treatment market is expected to reach US$ 569.4 Million by the end of 2029 with sales revenue expected to register a CAGR of 3.5% over the forecast period.
North America is estimated to hold the highest market share of nearly 28.1% of 2022 of the global market share in the skin tears treatment market with the USA being the leading contributor with a market value of over US$ 114.2 Million in 2022.
The demand for the skin tears treatment market is expected to register growth in Europe at a rate of 3.2% CAGR during the forecast period.
The Skin tears treatment in China is likely to observe growth with an impressive CAGR of 6.3% during the forecast period. The market in China is driven by the growing geriatric population, the increasing number of local players, and growing technological advancements.
Advanced wound healing therapies, rising efforts for increasing awareness, and advancements in technology are key trends driving sales of the skin tears treatment market across the globe.
Japan’s Skin Tears Treatment market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 3.2% CAGR during the forecast period. The South Korean market is expected to exhibit healthy growth of 2.8% CAGR during the forecast period.
The USA, China, Brazil, Germany, and India are the top 5 countries that are driving the demand for the skin tears treatment market.
Leading companies of skin tears treatment are 3M Health Care, ACell, Inc., BSN Medical GmbH (Essity AB), Cardinal Health, Inc., Coloplast A/S, ConvaTec Group Plc, Covalon Technologies Ltd., Medline Industries, Inc., Mölnlycke Health Care AB, Smith and Nephew Plc, Hollister Inc., Avery Dennison Corporation, Geistlich Pharma AG, Richardson Healthcare Ltd, Stedical Scientific, and Anika Therapeutics, Inc.
1. Executive Summary | Skin Tears Treatment Market 1.1. Global Market Outlook 1.2. Market Trends 1.3. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 4. Key Success Factors & Market Context 4.1. Parent Market Analysis 4.2. Epidemiology of Skin Tears, by Top Countries 4.3. Risk Factors for Skin Tears 4.4. Etiology of Skin Tears 4.5. Dressing Selection Criteria for Skin Tears 4.6. Pathway to Assessment & Treatment of Skin Tears 4.7. Key Promotional Strategies 4.8. Market Access & Reimbursement Landscape, by Country 5. Global Market Volume (Units) Analysis 2014 to 2021 and Forecast, 2022 to 2029 5.1. Historical Market Volume (Units) Analysis, 2014 to 2021 5.2. Current and Future Market Volume (Units) Projections, 2022 to 2029 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Market - Pricing Analysis 7. Global Market Value (US$ Million) Analysis 2014 to 2021 and Forecast, 2022 to 2029 7.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021 7.2. Current and Future Market Value (US$ Million) and Projections, 2022 to 2029 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Market Background 8.1. Macro-Economic Factors 8.1.1. Global GDP Growth Outlook 8.1.2. Global Healthcare Outlook 8.1.3. Income Per Capita Outlook 8.2. Forecast Factors - Relevance & Impact 8.2.1. Prevalence of Skin Tears 8.2.2. New Product Launches 8.2.3. Technology Advancements 8.2.4. Mergers and Acquisitions 8.3. Market Dynamics 8.3.1. Drivers 8.3.2. Restraints 8.3.3. Opportunity Analysis 9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Products, 2014 to 2021 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2029 9.3.1. Moisture-retentive Dressings 9.3.1.1. Mesh Dressings 9.3.1.2. Foam Dressings 9.3.1.3. Hydrogel Dressings 9.3.1.4. Silicone Dressings 9.3.1.5. Alginate Dressings 9.3.1.6. Acrylic Dressings 9.3.1.7. Hydrocolloid Dressings 9.3.1.8. Hydrofiber Dressings 9.3.2. Barrier Films 9.3.3. Hyaluronic Acid Wound Device 9.3.4. Contact Layer Dressings 9.3.5. 2-Octyl Cyanoacrolate Topical Bandages 9.3.6. Dressing Adhesives & Fixators 9.3.6.1. Adhesive Fixation Products 9.3.6.2. Non-adhesive Fixation Products 9.3.7. Gels & Creams 9.3.8. Skin Closure Strips 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Type of Skin Tear, 2014 to 2021 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Type of Skin Tear, 2022 to 2029 10.3.1. Type 1 Skin Tear 10.3.2. Type 2 Skin Tear 10.3.3. Type 3 Skin Tear 10.4. Market Attractiveness Analysis By Type of Skin Tear 11. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Distribution Channel, 2014 to 2021 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2022 to 2029 11.3.1. Hospital Pharmacies 11.3.2. Retail Pharmacies 11.3.3. Specialty Pharmacies 11.3.4. Mail Order Pharmacy 11.4. Market Attractiveness Analysis By Distribution Channel 12. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Region 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2014 to 2021 12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2022 to 2029 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029 13.1. Introduction 13.2. Historical Market Size (US$ Million) Analysis and Volume (Units) By Market Taxonomy, 2014 to 2021 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029 13.3.1. By Country 13.3.1.1. USA 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By Type of Skin Tear 13.3.4. By Distribution Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By Type of Skin Tear 13.4.4. By Distribution Channel 13.5. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Rest of Latin America 14.3.2. By Product 14.3.3. By Type of Skin Tear 14.3.4. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Type of Skin Tear 14.4.4. By Distribution Channel 14.5. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. United Kingdom 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Product 15.3.3. By Type of Skin Tear 15.3.4. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Type of Skin Tear 15.4.4. By Distribution Channel 15.5. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By Type of Skin Tear 16.3.4. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Type of Skin Tear 16.4.4. By Distribution Channel 16.5. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By Type of Skin Tear 17.3.4. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Type of Skin Tear 17.4.4. By Distribution Channel 17.5. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By Type of Skin Tear 18.3.4. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Type of Skin Tear 18.4.4. By Distribution Channel 18.5. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Northern Africa 19.3.1.3. South Africa 19.3.1.4. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By Type of Skin Tear 19.3.4. By Distribution Channel 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Type of Skin Tear 19.4.4. By Distribution Channel 19.5. Drivers and Restraints - Impact Analysis 20. Emerging Countries Market Analysis 2014 to 2021 and Forecast 2022 to 2029 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. China Market Analysis 20.2.1. Market Value Proportion Analysis by Market Taxonomy 20.2.2. Volume (Units) and Value (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy 20.2.2.1. By Product 20.2.2.2. By Type of Skin Tear 20.2.2.3. By Distribution Channel 20.2.3. China Market - Competition Landscape 20.3. India Market Analysis 20.3.1. Market Value Proportion Analysis by Market Taxonomy 20.3.2. Volume (Units) and Value (US$ Million) and Volume (Units)Analysis and Forecast by Market Taxonomy 20.3.2.1. By Product 20.3.2.2. By Type of Skin Tear 20.3.2.3. By Distribution Channel 20.3.3. India Market - Competition Landscape 20.4. Brazil Market Analysis 20.4.1. Market Value Proportion Analysis by Market Taxonomy 20.4.2. Market (Units) and Value (US$ Million) and Volume (Units)Analysis and Forecast by Market Taxonomy 20.4.2.1. By Product 20.4.2.2. By Type of Skin Tear 20.4.2.3. By Distribution Channel 20.4.3. Brazil Market - Competition Landscape 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Competition Benchmarking 21.3. Key Players Market Intensity Mapping, by Region 21.4. Market Share Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Deep Dive 22.2.1. 3M Health Care 22.2.1.1. Overview 22.2.1.2. Product Portfolio 22.2.1.3. Profitability by Market Segments (Product/Channel/Region) 22.2.1.4. Sales Footprint 22.2.1.5. Strategic Overview 22.2.1.5.1. Marketing Strategy 22.2.1.5.2. Product Strategy 22.2.1.5.3. Channel Strategy 22.2.2. ACell, Inc. 22.2.2.1. Overview 22.2.2.2. Product Portfolio 22.2.2.3. Profitability by Market Segments (Product/Channel/Region) 22.2.2.4. Sales Footprint 22.2.2.5. Strategic Overview 22.2.2.5.1. Marketing Strategy 22.2.2.5.2. Product Strategy 22.2.2.5.3. Channel Strategy 22.2.3. BSN Medical GmbH (Essity AB) 22.2.3.1. Overview 22.2.3.2. Product Portfolio 22.2.3.3. Profitability by Market Segments (Product/Channel/Region) 22.2.3.4. Sales Footprint 22.2.3.5. Strategic Overview 22.2.3.5.1. Marketing Strategy 22.2.3.5.2. Product Strategy 22.2.3.5.3. Channel Strategy 22.2.4. Cardinal Health, Inc. 22.2.4.1. Overview 22.2.4.2. Product Portfolio 22.2.4.3. Profitability by Market Segments (Product/Channel/Region) 22.2.4.4. Sales Footprint 22.2.4.5. Strategic Overview 22.2.4.5.1. Marketing Strategy 22.2.4.5.2. Product Strategy 22.2.4.5.3. Channel Strategy 22.2.5. Coloplast A/S 22.2.5.1. Overview 22.2.5.2. Product Portfolio 22.2.5.3. Profitability by Market Segments (Product/Channel/Region) 22.2.5.4. Sales Footprint 22.2.5.5. Strategic Overview 22.2.5.5.1. Marketing Strategy 22.2.5.5.2. Product Strategy 22.2.5.5.3. Channel Strategy 22.2.6. ConvaTec Group Plc 22.2.6.1. Overview 22.2.6.2. Product Portfolio 22.2.6.3. Profitability by Market Segments (Product/Channel/Region) 22.2.6.4. Sales Footprint 22.2.6.5. Strategic Overview 22.2.6.5.1. Marketing Strategy 22.2.6.5.2. Product Strategy 22.2.6.5.3. Channel Strategy 22.2.7. Covalon Technologies Ltd. 22.2.7.1. Overview 22.2.7.2. Product Portfolio 22.2.7.3. Profitability by Market Segments (Product/Channel/Region) 22.2.7.4. Sales Footprint 22.2.7.5. Strategic Overview 22.2.7.5.1. Marketing Strategy 22.2.7.5.2. Product Strategy 22.2.7.5.3. Channel Strategy 22.2.8. Medline Industries, Inc. 22.2.8.1. Overview 22.2.8.2. Product Portfolio 22.2.8.3. Profitability by Market Segments (Product/Channel/Region) 22.2.8.4. Sales Footprint 22.2.8.5. Strategic Overview 22.2.8.5.1. Marketing Strategy 22.2.8.5.2. Product Strategy 22.2.8.5.3. Channel Strategy 22.2.9. Mölnlycke Health Care AB 22.2.9.1. Overview 22.2.9.2. Product Portfolio 22.2.9.3. Profitability by Market Segments (Product/Channel/Region) 22.2.9.4. Sales Footprint 22.2.9.5. Strategic Overview 22.2.9.5.1. Marketing Strategy 22.2.9.5.2. Product Strategy 22.2.9.5.3. Channel Strategy 22.2.10. Smith and Nephew Plc 22.2.10.1. Overview 22.2.10.2. Product Portfolio 22.2.10.3. Profitability by Market Segments (Product/Channel/Region) 22.2.10.4. Sales Footprint 22.2.10.5. Strategic Overview 22.2.10.5.1. Marketing Strategy 22.2.10.5.2. Product Strategy 22.2.10.5.3. Channel Strategy 22.2.11. Hollister Inc 22.2.11.1. Overview 22.2.11.2. Product Portfolio 22.2.11.3. Profitability by Market Segments (Product/Channel/Region) 22.2.11.4. Sales Footprint 22.2.11.5. Strategic Overview 22.2.11.5.1. Marketing Strategy 22.2.11.5.2. Product Strategy 22.2.11.5.3. Channel Strategy 22.2.12. Avery Dennison Corporation 22.2.12.1. Overview 22.2.12.2. Product Portfolio 22.2.12.3. Profitability by Market Segments (Product/Channel/Region) 22.2.12.4. Sales Footprint 22.2.12.5. Strategic Overview 22.2.12.5.1. Marketing Strategy 22.2.12.5.2. Product Strategy 22.2.12.5.3. Channel Strategy 22.2.13. Geistlich Pharma AG 22.2.13.1. Overview 22.2.13.2. Product Portfolio 22.2.13.3. Profitability by Market Segments (Product/Channel/Region) 22.2.13.4. Sales Footprint 22.2.13.5. Strategic Overview 22.2.13.5.1. Marketing Strategy 22.2.13.5.2. Product Strategy 22.2.13.5.3. Channel Strategy 22.2.14. Richardson Healthcare Ltd 22.2.14.1. Overview 22.2.14.2. Product Portfolio 22.2.14.3. Profitability by Market Segments (Product/Channel/Region) 22.2.14.4. Sales Footprint 22.2.14.5. Strategic Overview 22.2.14.5.1. Marketing Strategy 22.2.14.5.2. Product Strategy 22.2.14.5.3. Channel Strategy 22.2.15. Stedical Scientific 22.2.15.1. Overview 22.2.15.2. Product Portfolio 22.2.15.3. Profitability by Market Segments (Product/Channel/Region) 22.2.15.4. Sales Footprint 22.2.15.5. Strategic Overview 22.2.15.5.1. Marketing Strategy 22.2.15.5.2. Product Strategy 22.2.15.5.3. Channel Strategy 22.2.16. Anika Therapeutics, Inc. 22.2.16.1. Overview 22.2.16.2. Product Portfolio 22.2.16.3. Profitability by Market Segments (Product/Channel/Region) 22.2.16.4. Sales Footprint 22.2.16.5. Strategic Overview 22.2.16.5.1. Marketing Strategy 22.2.16.5.2. Product Strategy 22.2.16.5.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Skin Tears Treatment Market
